Skip to content

The Symani Restore Study

An Early Feasibility Study for the Symani Surgical System

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07140731
Enrollment
15
Registered
2025-08-26
Start date
2025-09-20
Completion date
2027-09-01
Last updated
2025-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya Disease

Brief summary

A research study for a neurosurgical procedure in adult patients with Moyamoya disease

Detailed description

The purpose of this research is to assess the safety and effectiveness of the Symani Surgical System in adult patients with Moyamoya disease.

Interventions

To assess the safety and effectiveness of the Symani Surgical System

Sponsors

Jacobs institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients aged \>18. 2. Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment. 3. Patients agree to have the surgery and the anesthesia. 4. Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form. \-

Exclusion criteria

1. Patients who have bleeding or coagulation disorders in the past or present. 2. Any criteria that preclude prolonged anesthesia. 3. Hemodynamically unstable neurological exam. 4. Pressure dependent neurologic status.

Design outcomes

Primary

MeasureTime frameDescription
CT Imaging6 MonthsStable cerebral perfusion confirmed with CT Imaging

Countries

United States

Contacts

Primary ContactCARLOS PENA, PhD, MS
cpena@jacobsinstitute.org17168884814

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026